| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710446 | Null | 0.00352002370824895 | 0.44275445 |
| NSC 717067 | Null | 0.00352002370824895 | 0.53433711 |
| NSC 734626 | Null | 0.00352002370824895 | 0.22045315 |
| NSC 750937 | Null | 0.00352002370824895 | 0.14811809 |
| NSC 753222 | 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline | 0.00352002370824895 | 0.34219286 |
| NSC 754385 | 1-[bis(4,4'-aminophenyl)methylidenyl]-[3]ferrocenophane | 0.00352002370824895 | 0.019674255 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.00397405528023193 | 0.26590831 |
| NSC 205555 | Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- | 0.00397405528023196 | 0.50587303 |
| NSC 339638 | 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt | 0.00397405528023196 | 0.24503171 |
| NSC 609356 | Null | 0.00397405528023196 | 0.37855528 |